FDA Reviewer Retention Remains Priority In FY 2001 - User Fee Report
This article was originally published in The Tan Sheet
Executive Summary
FDA will implement ideas from employee focus groups in FY 2001 to try to improve the retention rate in its drug review divisions, the agency said in its fiscal 2000 Prescription Drug User Fee Act Financial Report.